Blood test breakthrough? new study aims to spot rare cancers earlier
NCT ID NCT06361641
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at a type of immune cell called monocytes in people with certain blood cancers (polycythemia vera, essential thrombocythemia, and myelofibrosis). Researchers will analyze blood samples from 70 newly diagnosed patients to find unique patterns in these cells. The goal is to see if these patterns can help confirm the diagnosis more accurately than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a new blood test that helps doctors diagnose these blood cancers more accurately and earlier.
What could go wrong
This is an early observational study with only 70 participants, so results may not apply to everyone. It is not testing a treatment, so it won't directly help patients yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOPROLIFERATIVE NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BESCOND Charles
NOT_YET_RECRUITINGCholet, Maine et Loire, 49325, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
GOUBAND Agathe
RECRUITINGAngers, Maine et Loire, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
TRUCHAN-GRACZYK Malgorzata
NOT_YET_RECRUITINGSaumur, Maine et Loire, 49400, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact